The growth of robotic surgery: from novelty to necessary infrastructure

Abstract

Robotic-assisted surgery has now progressed beyond early adoption, and across the world is moving from niche to mainstream. Best estimates (from aggregated counts and independent forecasts) suggest compound annual growth of about 11-15% through to 2030, at least. The United States, the EU-27 and APAC (Asia-Pacific) all show rising utilisation with similar trajectories. Manufacturer dynamics are also shifting, with Intuitive’s share easing from about 95% in 2012 to roughly 80% by 2030. In England, robot-supported procedures increased from fewer than 7,000 in 2014 to over 70,000 in 2023/24, and national targets are now for around 500,000 operations per year by 2035. The policy question has shifted from whether to integrate robotics to how to scale safely, equitably, and cost‑effectively, all whilst generating decision‑ready evidence. Early Value Assessment guidance from the UK’s NICE has firmly linked conditional recommendations to structured evidence generation.